comparemela.com
Home
Live Updates
Review Estimates Acne Risk With JAK Inhibitor Therapy : comp
Review Estimates Acne Risk With JAK Inhibitor Therapy : comp
Review Estimates Acne Risk With JAK Inhibitor Therapy
A systematic review and meta-analysis with more than 10,000 individuals showed a significant increase in acne associated with JAK inhibitors.
Related Keywords
Boston ,
Massachusetts ,
United States ,
Harvard University ,
Eli Lilly ,
Jeremy Martinez ,
Boehringer Ingelheim ,
Pfizer ,
Dexcel Pharma Technologies ,
Acne ,
Acne Vulgaris ,
Skin And Soft Tissue Infection ,
Meta Analysis ,
Adherence ,
Dherence To Medication Issues For Patients ,
Adverse Effects ,
Side Effects ,
Tyrosine Kinase ,
Patient Safety ,